Should high risk smoldering myeloma be treated outside a clinical trial: NO

Morie A. Gertz*, Iuliana Vaxman

*Corresponding author for this work

Research output: Contribution to journalComment/debate

2 Scopus citations
Original languageEnglish
Pages (from-to)2565-2567
Number of pages3
JournalLeukemia and Lymphoma
Volume62
Issue number11
DOIs
StatePublished - 2021

Cite this